University of Hertfordshire

From the same journal

By the same authors

Standard

Choosing Not to Take Phosphate Binders : The Role of Dialysis Patients' Medication Beliefs. / Wileman, Vari; Chilcot, Joseph; Norton, Sam; Hughes, Lyndsay; Wellsted, D.; Farrington, Ken.

In: Nephron Clinical Practice, Vol. 119, No. 3, 2011, p. c205-c213.

Research output: Contribution to journalArticle

Harvard

APA

Vancouver

Author

Wileman, Vari; Chilcot, Joseph; Norton, Sam; Hughes, Lyndsay; Wellsted, D.; Farrington, Ken / Choosing Not to Take Phosphate Binders : The Role of Dialysis Patients' Medication Beliefs.

In: Nephron Clinical Practice, Vol. 119, No. 3, 2011, p. c205-c213.

Research output: Contribution to journalArticle

Bibtex

@article{32c7965e8e964c84b667a43d9314c116,
title = "Choosing Not to Take Phosphate Binders: The Role of Dialysis Patients' Medication Beliefs",
author = "Vari Wileman and Joseph Chilcot and Sam Norton and Lyndsay Hughes and D. Wellsted and Ken Farrington",
note = "Copyright © 2011 S. Karger AG, Basel.",
year = "2011",
doi = "10.1159/000329106",
volume = "119",
pages = "c205--c213",
journal = "Nephron Clinical Practice",
issn = "1660-8151",
publisher = "S. Karger AG",
number = "3",

}

RIS

TY - JOUR

T1 - Choosing Not to Take Phosphate Binders

T2 - Nephron Clinical Practice

AU - Wileman,Vari

AU - Chilcot,Joseph

AU - Norton,Sam

AU - Hughes,Lyndsay

AU - Wellsted,D.

AU - Farrington,Ken

N1 - Copyright © 2011 S. Karger AG, Basel.

PY - 2011

Y1 - 2011

N2 - Objective: Patients with end-stage renal disease (ESRD) receiving haemodialysis are at risk of cardiovascular disease and bone disorders related to high levels of serum phosphate (PO(4)). Phosphate binders are an important treatment; however, non-adherence remains a significant issue. This study investigates whether patients' beliefs about medicines predict intentional non-adherence to phosphate binders. Method: This was a cross-sectional study of ESRD patients (n = 76). Non-adherence was measured in two ways: (1) the self-report Medication Adherence Questionnaire (MAQ) and (2) 3-month average level of serum phosphate. The Beliefs about Medicines questionnaire was used to assess general and specific beliefs towards phosphate medicines. Results: Eleven (14.5% of 76) patients reported being intentionally non-adherent to phosphate binders. Patients' beliefs that phosphate binders were less necessary were significantly associated with intentional self-reported non- adherence. Furthermore, patients with greater concerns about phosphate binders had higher serum phosphate levels. Conclusion: Assessing patient beliefs about medicines is a reliable indicator of intentional non-adherence to treatment with phosphate binders. These findings may help in identifying ways in which adherence rates to phosphate binders can be improved.

AB - Objective: Patients with end-stage renal disease (ESRD) receiving haemodialysis are at risk of cardiovascular disease and bone disorders related to high levels of serum phosphate (PO(4)). Phosphate binders are an important treatment; however, non-adherence remains a significant issue. This study investigates whether patients' beliefs about medicines predict intentional non-adherence to phosphate binders. Method: This was a cross-sectional study of ESRD patients (n = 76). Non-adherence was measured in two ways: (1) the self-report Medication Adherence Questionnaire (MAQ) and (2) 3-month average level of serum phosphate. The Beliefs about Medicines questionnaire was used to assess general and specific beliefs towards phosphate medicines. Results: Eleven (14.5% of 76) patients reported being intentionally non-adherent to phosphate binders. Patients' beliefs that phosphate binders were less necessary were significantly associated with intentional self-reported non- adherence. Furthermore, patients with greater concerns about phosphate binders had higher serum phosphate levels. Conclusion: Assessing patient beliefs about medicines is a reliable indicator of intentional non-adherence to treatment with phosphate binders. These findings may help in identifying ways in which adherence rates to phosphate binders can be improved.

U2 - 10.1159/000329106

DO - 10.1159/000329106

M3 - Article

VL - 119

SP - c205-c213

JO - Nephron Clinical Practice

JF - Nephron Clinical Practice

SN - 1660-8151

IS - 3

ER -